Hipro established Jiangsu Branch at Taizhou—China medical city. 36700㎡ factory in Taizhou to build is for R&D, production, administration, marketing, storage, logistics, and supporting living facilities. The main buildings include a comprehensive office, sales, and logistics distribution center, reagents production base, instruments production base, and matching facilities for living.
Hipro will invest RMB1.5 billion in 3-5 years to this center. Above 100 items of leading POCT products will launch to the production line, covering the most chronic and acute diseases.